Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Necrotizing Fascitis clinical trials
2 of 2 indexed Necrotizing Fascitis trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Necrotizing Fascitis: 2 US clinical trials tracked, 2 recruiting.
Necrotizing Fascitis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Eric R. Henderson, running 1 of these trials.
Enrollment posture brief
Registry condition necrotizing-fascitis
OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Necrotizing Fascitis lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Necrotizing Fascitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Necrotizing Fascitis is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
Eric R. Henderson
NCT06877793
The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
Benjamin T. Miller
NCT06857708
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Necrotizing Fascitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Necrotizing Fascitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Necrotizing Fascitis page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Necrotizing Fascitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Eric R. Henderson sponsors the most Necrotizing Fascitis trials on record, review their full trial history before evaluating a specific study. See Eric R. Henderson's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Necrotizing Fascitis condition card totals 2 registered trials; most-linked intervention Administration of indocyanine green (ICG) and fluorescence imaging; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.